The Product Stewardship Institute’s Scott Cassel recently submitted the following letter to the editor to the Washington Post in response to its October 15th article, The Drug Industry’s Triumph over the DEA.
The October 15th investigations article, “The Drug Industry’s Triumph over the DEA,” highlights the power of the pharmaceutical industry to avoid taking responsibility for their role in the opioid epidemic, which has torn apart families and imposed unacceptable health costs on society. One billion dollars worth of leftover drugs sits in U.S. medicine cabinets and has become a gateway to addiction, abuse, and accidental poisonings.
It’s time for the U.S. pharmaceutical industry to be held accountable for the massive quantities of medicine it puts on the market. Massachusetts, Vermont, and 18 counties or cities in California, Illinois, New York, and Washington have passed laws that require pharmaceutical companies to finance and/or manage jurisdiction-wide drug take-back programs designed to provide residents with safe and convenient medication drop-off locations at pharmacies, hospitals, and law enforcement offices.
We urge the Council of the District of Columbia to amend the Safe Disposal of Pharmaceuticals Amendment Act of 2017 (B22-0228) to require the industry to take back unwanted medicine and help alleviate the raging opioid epidemic.
Chief Executive Officer/Founder
Product Stewardship Institute